IL6 and neoplasm: Our results also showed that the levels of serum IFN-γ, IL-6, and TNF-α were not altered after three doses of MHC-I‒E6‒mEry treatment in MC38-HPV16 tumor-bearing mice compared to PBS-treated mice (Supplementary Fig. S7a‒c).